Seelos Therapeutics, Inc. announced the completion of its previously disclosed merger with Apricus Biosciences, Inc. The combined company changed its name to Seelos Therapeutics, Inc. Raj Mehra, Ph.D., Chairman, founder and CEO of Seelos will serve as the Chairman, CEO and President of the combined company, and Richard Pascoe, the former CEO of Apricus, will serve on the Board of Directors. Other board members include: Robin L. Smith, M.D., Chairman of the Board of The Stem for Life Foundation; Daniel J. O'Connor, CEO of OncoSec Medical, Inc.; and Brian Lian, Ph.D., CEO and President of Viking Therapeutics, Inc.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.77 USD | -6.85% | -21.39% | -84.44% |
05-16 | Seelos Therapeutics, Inc. announced that it expects to receive $1.137029 million in funding | CI |
05-14 | Seelos Therapeutics to Implement Reverse Stock Split to Regain Bourse Compliance | MT |
1st Jan change | Capi. | |
---|---|---|
-84.44% | 3.25M | |
+9.80% | 115B | |
+11.75% | 106B | |
-2.59% | 21.96B | |
-12.71% | 21.87B | |
-5.29% | 19.21B | |
-3.79% | 18.08B | |
-38.57% | 17.71B | |
+7.09% | 14.32B | |
+35.32% | 12.42B |
- Stock Market
- Equities
- SEEL Stock
- News Seelos Therapeutics, Inc.
- Seelos Therapeutics, Inc. Announces Executive Changes